^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    trastuzumab-melanotransferrin conjugate (BT2111)

    i
    Other names: BT2111, Transcend-Trastuzumab, BT-2111, MTfp-TZM

    Associations

    News
    Trials
    Company:
    Bioasis
    Drug class:
    HER2-targeted antibody-drug conjugate, Melanotransferrin modulator
    Related drugs:

    Associations

    News
    Trials